This medication is used to treat certain types of advanced lung cancer. It is also used to treat certain types of brain, breast, kidney, colon, or rectal cancer along with other cancer medicines.
Contraindicated in patients with hole in stomach or intestine, wound, and hypersensitivity.
Metastatic Carcinoma of the Colon or Rectum - Adults
IV infusion 5 or 10 mg/kg every 14 days in combination with IV 5-fluorouracilï¿½based chemotherapy. The recommended dosage is 5 mg/kg every 14 days when administered with irinotecan/5-fluorouracil/leucovorin, and 10 mg/kg every 14 days when administered with 5-fluorouracil/leucovorin/oxaliplatin.
This medication available in the form of injection, administered by health care provider, intravenously. It is usually given once every 14 days to treat breast cancer or cancer of the colon or rectum and once every 3 weeks to treat lung cancer
• It may reduce the number of clot-forming cells (platelets) in your blood. Avoid injuries.
• Caution should be exercised in patients with history of cancer and heart disease, congestive heart failure, high blood pressure, during pregnancy and lactation.
Changes in taste, constipation, diarrhea, increased thirst, indigestion, loss of appetite, mouth pain or sores, nausea, vomiting, black, tarry stools and dry mouth.
• Central Nervous System: Dizziness, tiredness and headache.
• Skin: Dry skin, hair loss, swelling, or redness at the injection site, rash, hives, itching and swelling of the mouth, face, lips, or tongue.
• Eye and ENT: Nosebleed, stuffy or runny nose and voice changes.
♦ • Heart: Difficulty breathing, tightness in the chest, congestive heart failure, calf pain or tenderness and chest pain.
• Miscellaneous: Muscle pain, sluggishness, weakness and weight loss.
Do not administer or mix bevacizumab with dextrose solutions.
It is normally handled and stored by healthcare providers.
Subscribe to our Free Newsletters!